BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Komen J, Westerbeek EY, Kolkman RW, Roesthuis J, Lievens C, van den Berg A, van der Meer AD. Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device. Lab Chip 2020;20:3167-78. [PMID: 32729598 DOI: 10.1039/d0lc00419g] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Mistretta M, Gangneux N, Manina G. Microfluidic dose-response platform to track the dynamics of drug response in single mycobacterial cells. Sci Rep 2022;12:19578. [PMID: 36379978 DOI: 10.1038/s41598-022-24175-9] [Reference Citation Analysis]
2 Carvalho V, Bañobre-lópez M, Minas G, Teixeira SF, Lima R, Rodrigues RO. The integration of spheroids and organoids into organ-on-a-chip platforms for tumour research: A review. Bioprinting 2022;27:e00224. [DOI: 10.1016/j.bprint.2022.e00224] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Bourguignon N, Karp P, Attallah C, Chamorro DA, Oggero M, Booth R, Ferrero S, Bhansali S, Pérez MS, Lerner B, Helguera G. Large Area Microfluidic Bioreactor for Production of Recombinant Protein. Biosensors 2022;12:526. [DOI: 10.3390/bios12070526] [Reference Citation Analysis]
4 Guo Y, Liu J, Tang Q, Li C, Zhang Y, Wang Y, Wang Y, Bi Y, Snow CD, Kipper MJ, Belfiore LA, Tang J. Lanthanide (Eu3+/Tb3+)-Loaded γ-Cyclodextrin Nano-Aggregates for Smart Sensing of the Anticancer Drug Irinotecan. Int J Mol Sci 2022;23:6597. [PMID: 35743042 DOI: 10.3390/ijms23126597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Singh D, Deosarkar SP, Cadogan E, Flemington V, Bray A, Zhang J, Reiserer RS, Schaffer DK, Gerken GB, Britt CM, Werner EM, Gibbons FD, Kostrzewski T, Chambers CE, Davies EJ, Montoya AR, Fok JHL, Hughes D, Fabre K, Wagoner MP, Wikswo JP, Scott CW. A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models. PLoS Biol 2022;20:e3001624. [DOI: 10.1371/journal.pbio.3001624] [Reference Citation Analysis]
6 Komen J, van Neerven SM, Bossink EGBM, de Groot NE, Nijman LE, van den Berg A, Vermeulen L, van der Meer AD. The Effect of Dynamic, In Vivo-like Oxaliplatin on HCT116 Spheroids in a Cancer-on-Chip Model Is Representative of the Response in Xenografts. Micromachines 2022;13:739. [DOI: 10.3390/mi13050739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Mistretta M, Gangneux N, Manina G. Dynamics of drug response in single mycobacterial cells by microfluidic dose-response assay.. [DOI: 10.1101/2022.04.03.486879] [Reference Citation Analysis]
8 Lohasz C, Loretan J, Sterker D, Görlach E, Renggli K, Argast P, Frey O, Wiesmann M, Wartmann M, Rausch M, Hierlemann A. A Microphysiological Cell-Culturing System for Pharmacokinetic Drug Exposure and High-Resolution Imaging of Arrays of 3D Microtissues. Front Pharmacol 2021;12:785851. [PMID: 35342386 DOI: 10.3389/fphar.2021.785851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gonçalves IM, Carvalho V, Rodrigues RO, Pinho D, Teixeira SFCF, Moita A, Hori T, Kaji H, Lima R, Minas G. Organ-on-a-Chip Platforms for Drug Screening and Delivery in Tumor Cells: A Systematic Review. Cancers 2022;14:935. [DOI: 10.3390/cancers14040935] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Dai B, Long Y, Wu J, Huang S, Zhao Y, Zheng L, Tao C, Guo S, Lin F, Fu Y, Zhang D, Zhuang S. Generation of flow and droplets with an ultra-long-range linear concentration gradient. Lab Chip 2021;21:4390-400. [PMID: 34704106 DOI: 10.1039/d1lc00749a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
11 Carvalho V, Rodrigues RO, Lima RA, Teixeira S. Computational Simulations in Advanced Microfluidic Devices: A Review. Micromachines (Basel) 2021;12:1149. [PMID: 34683199 DOI: 10.3390/mi12101149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
12 Petreus T, Cadogan E, Hughes G, Smith A, Pilla Reddy V, Lau A, O'Connor MJ, Critchlow S, Ashford M, Oplustil O'Connor L. Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response. Commun Biol 2021;4:1001. [PMID: 34429505 DOI: 10.1038/s42003-021-02526-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
13 Castro F, Leite Pereira C, Helena Macedo M, Almeida A, José Silveira M, Dias S, Patrícia Cardoso A, José Oliveira M, Sarmento B. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening. Adv Drug Deliv Rev 2021;175:113824. [PMID: 34090966 DOI: 10.1016/j.addr.2021.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
14 Zhou Z, Zhu J, Jiang M, Sang L, Hao K, He H. The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development. Pharmaceutics 2021;13:704. [PMID: 34065907 DOI: 10.3390/pharmaceutics13050704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]